The prospective observational clinical study is now underway, involving patients with acute, complete traumatic spinal cord injury, who will be monitored over a 12-month period during their neurorehabilitation journey.
Authorized by the respective Ethics Committees, the study has begun with patient enrollment at the Grande Ospedale Metropolitano Niguarda in Milan, the Villa Beretta Neurorehabilitation Center in Lecco, and the Papa Giovanni XXIII Hospital in Bergamo.
With this, Hemera enters the clinical phase, aiming to monitor the physiological evolution of the disease in patients over the course of one year from the trauma, to gain a detailed understanding of spinal cord injuries and the progression of severe post-traumatic conditions for the benefit of the entire scientific and clinical community, and to collect clinical data in support of the subsequent interventional pharmacological study, scheduled to begin in 2025.